Diabetes Metab J.  2020 Feb;44(1):113-124. 10.4093/dmj.2018.0216.

Incidence and Risk Factors for Dementia in Type 2 Diabetes Mellitus: A Nationwide Population-Based Study in Korea

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea. nhkendo@gmail.com
  • 2Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 3Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Family Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. ksmpdh@korea.ac.kr
  • 5Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • 6Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Diabetes mellitus is associated with an increased risk of dementia. We aimed to comprehensively analyze the incidence and risk factors for dementia and young-onset dementia (YOD) in diabetic patients in Korea using the National Health Insurance Service data.
METHODS
Between January 1, 2009 and December 31, 2012, a total of 1,917,702 participants with diabetes were included and followed until the date of dementia diagnosis or until December 31, 2015. We evaluated the incidence and risk factors for all dementia, Alzheimer's disease (AD), and vascular dementia (VaD) by Cox proportional hazards analyses. We also compared the impact of risk factors on the occurrence of YOD and late-onset dementia (LOD).
RESULTS
During an average of 5.1 years of follow-up, the incidence of all types of dementia, AD, or VaD was 9.5, 6.8, and 1.3/1,000 person-years, respectively, in participants with diabetes. YOD comprised 4.8% of all dementia occurrence, and the ratio of AD/VaD was 2.1 for YOD compared with 5.5 for LOD. Current smokers and subjects with lower income, plasma glucose levels, body mass index (BMI), and subjects with hypertension, dyslipidemia, vascular complications, depression, and insulin treatment developed dementia more frequently. Vascular risk factors such as smoking, hypertension, and previous cardiovascular diseases were more strongly associated with the development of VaD than AD. Low BMI and a history of stroke or depression had a stronger influence on the development of YOD than LOD.
CONCLUSION
The optimal management of modifiable risk factors may be important for preventing dementia in subjects with diabetes mellitus.

Keyword

Alzheimer disease; Dementia; Dementia, vascular; Diabetes mellitus, type 2; Risk factors

MeSH Terms

Alzheimer Disease
Blood Glucose
Body Mass Index
Cardiovascular Diseases
Dementia*
Dementia, Vascular
Depression
Diabetes Mellitus
Diabetes Mellitus, Type 2*
Diagnosis
Dyslipidemias
Follow-Up Studies
Humans
Hypertension
Incidence*
Insulin
Korea*
National Health Programs
Risk Factors*
Smoke
Smoking
Stroke
Insulin
Smoke

Figure

  • Fig. 1 Incidence rates of (A) all-cause dementia, (B) Alzheimer's disease (AD), and (C) vascular dementia (VaD) based on age group.

  • Fig. 2 Hazard ratios (HRs) for all-cause dementia, Alzheimer's disease (AD), and vascular dementia (VaD) based on (A) body mass index (BMI) or (B) waist circumference. Analyses were adjusted for age, sex, smoking, alcohol intake, exercise, income, plasma glucose concentration, duration of diabetes, dyslipidemia, hypertension, diabetic retinopathy, chronic kidney disease, stroke, ischemic heart disease, depression, number of oral hypoglycemic agents, and treatment with insulin.


Cited by  3 articles

Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
Jin Hwa Kim
Diabetes Metab J. 2020;44(2):356-357.    doi: 10.4093/dmj.2020.0072.

Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study
Yunjung Cho, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee
Endocrinol Metab. 2021;36(2):424-435.    doi: 10.3803/EnM.2020.935.

Metabolically healthy obesity: it is time to consider its dynamic changes
Yun Kyung Cho, Chang Hee Jung
Cardiovasc Prev Pharmacother. 2022;4(4):123-131.    doi: 10.36011/cpp.2022.4.e19.


Reference

1. Prince M, Guerchet M, Prina M. Alzheimer's Disease International. Global Observatory for Ageing and Dementia Care. Policy brief for heads of government: the global impact of dementia 2013–2050. London: Alzheimer's Disease International;2013.
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5:64–74.
Article
3. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 1999; 52:78–84.
4. Ninomiya T. Diabetes mellitus and dementia. Curr Diab Rep. 2014; 14:487.
Article
5. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, Almeida OP, Davis TM. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 2008; 51:241–248.
Article
6. Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, Chiang CH, Huang PH, Chen TJ, Lin SJ, Chen JW, Chan WL. Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study. PLoS One. 2014; 9:e87095.
Article
7. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia. 2009; 52:1031–1039.
Article
8. Haroon NN, Austin PC, Shah BR, Wu J, Gill SS, Booth GL. Risk of dementia in seniors with newly diagnosed diabetes: a population-based study. Diabetes Care. 2015; 38:1868–1875.
Article
9. Vanden Heuvel A, Hudson C, Cargill J. Australian Institute of Health and Welfare. Dementia in Australia. Canberra: Australian Institute of Health and Welfare;2012.
10. Draper B, Withall A. Young onset dementia. Intern Med J. 2016; 46:779–786.
Article
11. Vieira RT, Caixeta L, Machado S, Silva AC, Nardi AE, Arias-Carrion O, Carta MG. Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health. 2013; 9:88–95.
Article
12. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; 46:e15.
Article
13. Yang HK, Han K, Kwon HS, Park YM, Cho JH, Yoon KH, Kang MI, Cha BY, Lee SH. Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea. Sci Rep. 2016; 6:30329.
Article
14. Bassett J. International Diabetes Institute. World Health Organization Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia;2000.
15. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002; 37:409–415.
Article
16. Lee YH, Han K, Ko SH, Ko KS, Lee KU. Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Data analytic process of a nationwide population-based study using national health information database established by National Health Insurance Service. Diabetes Metab J. 2016; 40:79–82.
Article
17. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139:137–147.
Article
18. Suh GH, Shah A. A review of the epidemiological transition in dementia: cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr Scand. 2001; 104:4–11.
19. Kim YJ, Han JW, So YS, Seo JY, Kim KY, Kim KW. Prevalence and trends of dementia in Korea: a systematic review and meta-analysis. J Korean Med Sci. 2014; 29:903–912.
Article
20. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012; 42:484–491.
Article
21. Tuligenga RH, Dugravot A, Tabak AG, Elbaz A, Brunner EJ, Kivimaki M, Singh-Manoux A. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014; 2:228–235.
Article
22. Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. N Engl J Med. 2013; 369:540–548.
Article
23. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012; 69:1170–1175.
Article
24. van den Berg E, de Craen AJ, Biessels GJ, Gussekloo J, Westendorp RG. The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia. 2006; 49:2015–2023.
Article
25. Kivimaki M, Luukkonen R, Batty GD, Ferrie JE, Pentti J, Nyberg ST, Shipley MJ, Alfredsson L, Fransson EI, Goldberg M, Knutsson A, Koskenvuo M, Kuosma E, Nordin M, Suominen SB, Theorell T, Vuoksimaa E, Westerholm P, Westerlund H, Zins M, Kivipelto M, Vahtera J, Kaprio J, Singh-Manoux A, Jokela M. Body mass index and risk of dementia: analysis of individual-level data from 1.3 million individuals. Alzheimers Dement. 2018; 14:601–609.
26. Singh-Manoux A, Dugravot A, Shipley M, Brunner EJ, Elbaz A, Sabia S, Kivimaki M. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimers Dement. 2018; 14:178–186.
Article
27. Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013; 35:51–65.
Article
28. Mott JW, Wang J, Thornton JC, Allison DB, Heymsfield SB, Pierson RN Jr. Relation between body fat and age in 4 ethnic groups. Am J Clin Nutr. 1999; 69:1007–1013.
Article
29. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003; 74:1206–1209.
Article
30. Garre-Olmo J, Genis Batlle D, del Mar Fernandez M, Marquez Daniel F, de Eugenio Huelamo R, Casadevall T, Turbau Recio J, Turon Estrada A, Lopez-Pousa S. Registry of Dementia of Girona Study Group (ReDeGi Study Group). Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology. 2010; 75:1249–1255.
Article
31. Heath CA, Mercer SW, Guthrie B. Vascular comorbidities in younger people with dementia: a cross-sectional population-based study of 616 245 middle-aged people in Scotland. J Neurol Neurosurg Psychiatry. 2015; 86:959–964.
32. Cations M, Draper B, Low LF, Radford K, Trollor J, Brodaty H, Sachdev P, Gonski P, Broe GA, Withall A. Non-genetic risk factors for degenerative and vascular young onset dementia: results from the INSPIRED and KGOW studies. J Alzheimers Dis. 2018; 62:1747–1758.
Article
33. Nordstrom P, Nordstrom A, Eriksson M, Wahlund LO, Gustafson Y. Risk factors in late adolescence for young-onset dementia in men: a nationwide cohort study. JAMA Intern Med. 2013; 173:1612–1618.
34. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011; 7:323–331.
Article
35. Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res. 2007; 32:1749–1756.
Article
36. Kohler S, Thomas AJ, Lloyd A, Barber R, Almeida OP, O'Brien JT. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010; 196:143–149.
37. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006; 63:161–167.
Article
38. Herman FJ, Simkovic S, Pasinetti GM. Neuroimmune nexus of depression and dementia: shared mechanisms and therapeutic targets. Br J Pharmacol. 2019; 176:3558–3584.
Article
39. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, Ayata C, Frosch MP, Greenberg SM, Bacskai BJ. Cerebrovascular lesions induce transient β-amyloid deposition. Brain. 2011; 134(Pt 12):3697–3707.
Article
40. Doyle KP, Buckwalter MS. Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia? Brain Behav Immun. 2017; 64:1–8.
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr